Article | March 21, 2024

CMC And Regulatory Considerations For CRISPR Therapies

Guidance-Puzzle-Regulatory-iStock-489087670

Chemistry, Manufacturing, and Controls (CMC) is a process that ensures products are produced safely, consistently, and of high quality by designing and testing manufacturing processes, materials, and final products. This presents a different set of guidelines from Current Good Manufacturing Practices (cGMP), as the former refers to product quality, while the latter refers to quality management. But why is CMC so important during all stages of the drug development cycle after drug discovery?

This article explores the details of CMC and Critical Quality Attributes (CQAs), which play an important role in gene editing. CQA's are properties that should be within specific limits to ensure product quality. You will also learn about the Common Technical Document (CTD), which is a set of specifications for registering medicines, detailing how the gRNA is manufactured, controlled, tested, and stored in Module 3.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene